And, Rivian Automotive reaffirms target.
Plus, Rivian's senior notes flop.
And the future of Novavax is in doubt.
Plus, Rivian’s production declines.
And, a biotech company jumped 85%.
Plus, Rivian's preorder growth.
Plus, Amazon's holiday forecast.
Plus, Feds call out crypto risk.
Plus, Rivian’s supply chain.
Plus, Tesla plans for layoffs.
Plus, 3 commodity-based ETFs.
Does the valuation make sense?